Islet amyloid polypeptide ? a novel controversy in diabetes research
- 1 April 1992
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 35 (4), 297-303
- https://doi.org/10.1007/bf00401195
Abstract
No abstract availableThis publication has 90 references indexed in Scilit:
- Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanismBiochemical and Biophysical Research Communications, 1991
- Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreasBiochemical and Biophysical Research Communications, 1990
- Regional distribution and molecular forms of rat islet amyloid polypeptideBiochemical and Biophysical Research Communications, 1990
- Islet amyloid polypeptide, a novel pancreatic peptide, is a circulating hormone secreted under glucose stimulationBiochemical and Biophysical Research Communications, 1990
- The effect of amylin and calcitonin gene-related peptide on insulin-stimulated glucose transport in the diaphragmBiochemical and Biophysical Research Communications, 1990
- The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in catsBiochemical and Biophysical Research Communications, 1990
- Islet amyloid polypeptide (IAPP;Amylin) influences the endocrine but not the exocrine rat pancreasBiochemical and Biophysical Research Communications, 1990
- Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentrationBiochemical and Biophysical Research Communications, 1989
- Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic isletsBiochemical and Biophysical Research Communications, 1989
- Amyloid fibrils formed from a segment of the pancreatic islet amyloid proteinBiochemical and Biophysical Research Communications, 1988